MAPT and Alzheimer disease: Our preclinical studies indicate that bilateral hippocampal delivery of AAV-NF-α1/CPE in pre-symptomatic male 3xTg-AD mice prevents progression of AD later in life, including rescuing cognitive dysfunction, tau hyperphosphorylation and APP/ Aβ42 overexpression.